Paranovus Entertainment Technology Ltd. current report, Q3 FY2021

SEC Form 6-K Summary

Filing company: Happiness Biotech Group Limited, not Paranovus Entertainment Technology Ltd. The provided filing is a Form 6-K dated September 13, 2021, covering September 2021.

Business Context and Reporting Period

The filing concerns the company’s 2021 annual general meeting of shareholders. It furnishes the notice of meeting and proxy card to be mailed to shareholders. The filing identifies the company as a Cayman Islands exempted company with principal executive offices in Fujian Province, China, and confirms that it files annual reports on Form 20-F.

Financial and Operating Metrics

The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, operating results, or other financial metrics.

Material Changes Versus Prior Period

The filing does not report financial or operational changes versus any prior comparable period.

Guidance, Outlook, Risks, and Unusual Items

The filing does not provide management guidance, an outlook, risk disclosures, contingencies, or unusual financial items. Its purpose is limited to furnishing annual-meeting materials.

Key Facts to Verify

  • Verify the company identity: the source document names Happiness Biotech Group Limited, while the request metadata names Paranovus Entertainment Technology Ltd.
  • Review Exhibit 99.1 for the detailed 2021 annual meeting notice, including meeting date, agenda, shareholder proposals, and voting procedures.
  • Review Exhibit 99.2 for the proxy card and matters submitted for shareholder approval.
  • Confirm the company’s subsequent Form 20-F or other filings for financial performance, liquidity, debt, and material risks, which are not included in this 6-K.